Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: Relationship to interleukin-4 and eosinophil counts

European Respiratory Journal

Volumn 9, Issue 5, 1996, Pages 899-904

  Kroegel, C ^a   Julius, P ^b   Matthys, H ^b   Virchow Jr , J C ^b   Luttmann, W ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Allergic asthma; asthma pathogenesis; bronchoalveolar eosinophils; interleukin 13; interleukin 4; segmental allergen provocation

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; EOSINOPHIL; FEMALE; HUMAN; LEUKOCYTE COUNT; LUNG LAVAGE; MALE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; ALLERGENS; ANALYSIS OF VARIANCE; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; MALE;

EID: 0029982434     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09050899     Document Type: Article

References (31)

1. Spry CFJ. In: Eosinophils: a comprehensive review and guide to the scientific and medical literature. Oxford, New York, Tokyo, Oxford University Press, 1988.
2. Kroegel C, Warner JA, Matthys H, Virchow JC Jr. Pulmonary immune cells in health and disease: the eosinophil leukocyte. Part II. Eur Respir J 1994; 7: 743-760.
3. Horn BR, Robin ED, Theodore J, von Kessel A. Total eosinophil counts in the management of bronchial asthma. N Engl J Med 1975; 292: 1152-1155.
4. Burrows B, Hasan FM, Barbee RM, Halonen M, Levowitz MD. Epidemiological observations on eosinophilia and its relation to respiratory disease. Am Rev Respir Dis 1980; 122: 709-715.
5. Durham SR, Kay AB. Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions. Clin Allergy 1985; 15: 411-418.
6. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
7. Corrigan CJ, Kay AB. CD4 T-lymphocyte activation in acute severe asthma: relationship to disease severity and atopic status. Am Rev Respir Dis 1990; 141: 970-977.
8. Walker C, Virchow JC Jr, Bruijnzeel PLB, Blaser K. T-cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991; 146: 1829-1835.
9. Bradley BL, Azzawi M, Jacobson M, et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991; 88: 661-674.
10. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow J-C Jr. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992; 146: 109-115.
11. Bochner B, Friedman B, Krishnaswami G, Schleimer RP, Lichtenstein LM, Kroegel C. Episodic eosinophiliamyalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte/macrophage colony-stimulating factor. J Allergy Clin Immunol 1991; 88: 629-639.
12. McKenzie ANJ, Li X, Largaespada DA, et al. Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J Immunol 1993; 150: 5436-5444.
13. Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362: 248-250.
14. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995; 154: 799-803.
15. Nakajima H, Sano H, Nishimura S, Yoshida S, Iwamoto I. Role of vascular adhesion molecule-1/very late activation antigen-4 and intercellular adhesion molecule/ lymphocyte function-associated antigen-1 interaction in antigen-induced eosinophil and T-cell recruitment into tissue. J Exp Med 1994; 179: 1145-1154.
16. 4 and IgE synthesis and CD23 expression by human B-cells. Proc Natl Acad Sci USA 1993; 90: 3730-3734.
17. de Waal Malefyt R, Figdor CG, Huijbens R, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993; 151: 6370-6381.
18. Herbert JM, Savi P, Laplace MC, et al. IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett 1993; 328: 268-270.
19. Muzio M, Re F, Sironi M, et al. Interleukin-13 induces the production of interleukin-1 receptor antagonists (IL-1Ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1Ra in human monocytic cells. Blood 1994; 83: 1738-1743.
20. Nilsson G, Nilsson K. Effects of interleukin (IL)-13 on immediate-early gene expression, phenotype and differentiation of human mast cells: comparison with IL-4. Eur J Immunol 1995; 25: 870-873.
21. Luttmann W, Knöchel B, Förster M, Matthys H, Virchow JC Jr, Kroegel C. Activation of human blood eosinophils by interleukin-13. J Immunol 1996; submitted.
22. National Heart, Lung and Blood Institute. International consensus report on diagnosis and treatment of asthma. NHLBI publication No. 92-3091. Eur Respir J 1992; 5: 601-641.
23. Kroegel C, Liu MC, Hubbard WC, Lichtenstein LM, Bochner BS. Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeniety and prostanoid production. J Allergy Clin Immunol 1994; 93: 725-734.
24. Virchow JC Jr, Walker C, Häfner D, et al. T-cells and cytokines in bronchoalveolar lavage fluid after segmental allergen challenge in atopic asthma. Am J Respir Crit Care Med 1995; 151: 960-968.
25. Sedgwick JB, Calhoun WJ, Gleich GJ, et al. Immediate and later airway response of allergy rhinitis patients to segmental allergy challenge. Am Rev Respir Dis 1991; 144: 1274-1281.
26. Kato M, Liu MC, Stealey BA, et al. Production of granulocyte/macrophage colon-stimulating factor in human airways during allergen-induced late-phase reaction in atopic subjects. Lymphokine Cytokine Res 1992; 11: 287-292.
27. Defrance T, Carayon P, Billian G, et al. Interleukin-13 is a B-cell stimulating factor. J Exp Med 1994; 179: 135-143.
28. Huang SK, Xiao HQ, Kleine-Tebbe J, et al. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 1995; 155: 2688-2694.
29. Zuwarski O, de Vries JE. IL-13 and IL-4 like cytokine that acts on monocytes and B-cells, but not on T-cells. Immunol Today 1994; 15: 19-26.
30. Malefyt RD, Abrams HS, Zurawski SM, et al. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T-cells clones and EBV transformed B-cells. Int Immunol 1995; 7: 1405-1416.
31. Brodey K, Semper AE, Madden J, et al. Cytokine mRNA pattern in BAL T-cell clones from asthmatic airways (Abstract). J Allergy Clin Immunol 1995; 95: 279.